亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Pregnancy outcomes in women with primary Sjögren's syndrome: an analysis of data from the multicentre, prospective, GR2 study

医学 妊娠期 产科 人口 怀孕 前瞻性队列研究 妇科 儿科 内科学 遗传学 生物 环境卫生
作者
G. Martin de Frémont,Nathalie Costedoat-Chalumeau,Estibaliz Lazaro,Rakiba Belkhir,G. Guettrot-Imbert,Nathalie Morel,Gaëtane Nocturne,Anna Moltó,Tiphaine Miquel Goulenok,Élisabeth Diot,Laurent Pérard,Nicole Ferreira-Maldent,Maelle le Besnerais,Nicolas Limal,Nihal Martis,Noémie Abisror,Odile Souchaud Debouverie,Christophe Richez,Vincent Sobanski,F. Maurier
出处
期刊:The Lancet Rheumatology [Elsevier BV]
卷期号:5 (6): e330-e340 被引量:45
标识
DOI:10.1016/s2665-9913(23)00099-1
摘要

Background Adverse pregnancy outcomes in women with primary Sjögren's syndrome have only been evaluated retrospectively using heterogeneous methods and with contradictory results. We aimed to describe adverse pregnancy, delivery, and birth outcome risks in pregnant women with primary Sjögren's syndrome compared with those of a matched general population in France, and to identify factors predictive of disease flares or adverse pregnancy outcomes. Methods We conducted a multicentre, prospective, cohort study in France using the GR2 (Groupe de Recherche sur la Grossesse et les Maladies Rares) registry. Women from the GR2 study were eligible if they had conceived before March, 2021, had primary Sjögren's syndrome according to the American College of Rheumatology and European Alliance of Associations for Rheumatology (EULAR) 2016 classification criteria, and had an ongoing pregnancy at 12 weeks of gestation. In women who entered in the registry with pregnancies before 18 weeks of gestation, we sought to identify factors associated with primary Sjögren's syndrome flare (≥3-point increase in EULAR Sjögren's Syndrome Disease Activity Index [ESSDAI] score) or adverse pregnancy outcomes (fetal or neonatal death, placental insufficiency leading to a preterm delivery [<37 weeks of gestation], or small-for-gestational-age birthweight). A matched controlled study compared adverse pregnancy, delivery, and birth outcome rates between pregnant women with primary Sjögren's syndrome from the GR2 registry and matched controls from the general population included in the last French perinatal survey (Enquête Nationale Périnatale 2016). Findings 1944 pregnancies were identified in the GR2 cohort, of which 106 pregnancies in 96 women with primary Sjögren's syndrome were included in this analysis. The median age at pregnancy onset was 33 years (IQR 31–36). 87 (83%) of 105 pregnancies (with ethnicity data) were in White women, 18 (17%) were in Black women; 92 (90%) of 102 had previous systemic activity (ESSDAI score of ≥1; data missing in four pregnancies), and 48 (45%) of 106 had systemic activity at inclusion. Of 93 pregnancies included at week 18 of gestation or earlier, primary Sjögren's syndrome flares occurred in 12 (13%). No baseline parameters were associated with primary Sjögren's syndrome flare. Four twin pregnancies and one medical termination were excluded from the adverse pregnancy outcome analysis; of the remaining 88, adverse pregnancy outcomes occurred in six (7%). Among pregnancies in women with data for antiphospholipid antibodies (n=55), antiphospholipid antibody positivity was more frequent among pregnancies with adverse outcomes (two [50%] of four pregnancies) compared with those without adverse outcomes (two [4%] of 51 pregnancies; p=0·023). Anti-RNP antibody positivity was also more frequent among pregnancies with adverse outcomes than those without, although this was not statistically significant. In the matched controlled study, adverse pregnancy outcomes occurred in nine (9%) of 105 pregnancies in women with primary Sjögren's syndrome and 28 (7%) of the 420 matched control pregnancies; adverse pregnancy outcomes were not significantly associated with primary Sjögren's syndrome (odds ratio 1·31, 95% CI 0·53–2·98; p=0·52). Interpretation Pregnancies in women with primary Sjögren's syndrome had very good prognoses for mothers and fetuses, with no overall increase in adverse pregnancy outcome risk compared with the general population. Women with antiphospholipid antibodies or anti-RNP antibodies require close monitoring, because these factors might be associated with a higher risk of adverse pregnancy outcomes. Funding Lupus France, Association des Sclérodermiques de France, Association Gougerot Sjögren, Association Francophone Contre la Polychondrite Chronique Atrophiante, AFM-Telethon, Société Nationale Française de Médecine Interne, Société Française de Rhumatologie, Cochin Hospital, French Health Ministry, Fondation for Research in Rheumatology, Association Prix Véronique Roualet, Union Chimique Belge.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
科研通AI6.3的应助被刻苦灯泡采纳,获得10
2秒前
yy完成签到 ,获得积分10
7秒前
PeizeWu完成签到,获得积分10
8秒前
二氧化碳喲完成签到,获得积分10
9秒前
10秒前
浅荫完成签到,获得积分10
12秒前
thisXiao6发布了新的文献求助10
15秒前
斯文尔珍完成签到,获得积分10
18秒前
小华完成签到 ,获得积分10
20秒前
小二郎的应助被hyxiaoren采纳,获得20
23秒前
28秒前
隐形的冷亦完成签到,获得积分10
32秒前
盒子的应助被thisXiao6采纳,获得30
33秒前
labor发布了新的文献求助30
33秒前
34秒前
35秒前
852的应助被亚历山大采纳,获得10
35秒前
37秒前
41秒前
cxw陈祥薇完成签到 ,获得积分10
42秒前
刻苦灯泡发布了新的文献求助10
42秒前
44秒前
小鱼儿发布了新的文献求助10
45秒前
郑嘉辉完成签到 ,获得积分10
46秒前
稳重又琴发布了新的文献求助60
48秒前
1分钟前
1分钟前
亚历山大发布了新的文献求助10
1分钟前
2589发布了新的文献求助20
1分钟前
筝zheng完成签到 ,获得积分10
1分钟前
FashionBoy的应助被小黑桃采纳,获得10
1分钟前
包容的听兰完成签到,获得积分10
1分钟前
亚历山大完成签到,获得积分10
1分钟前
坦率黑米发布了新的文献求助10
1分钟前
Akim的应助被坦率黑米采纳,获得10
1分钟前
suzhenyue的应助被坦率黑米采纳,获得10
1分钟前
顾矜的应助被坦率黑米采纳,获得30
1分钟前
1分钟前
1分钟前
涂豆泥发布了新的文献求助10
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8172954
求助须知:如何正确求助?哪些是违规求助? 9565479
关于积分的说明 21780029
捐赠科研通 7764837
什么是DOI,文献DOI怎么找? 3431499
关于科研通互助平台的介绍 2555519
邀请新用户注册赠送积分活动 2476579